The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
2021 · Science Translational Medicine · 489 citations
https://doi.org/10.1126/scitranslmed.abf1906
M
Maren de Vries
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
2.2K
Citations
16
h-index
18
i10-index
Maren de Vries is an academic researcher from New York University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & interferon and immune responses. The author has an h-index of 16, co-authored 26 publications.
ORCID: 0000-0003-1059-8344Papers by this author
worksThe NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target
2021 · Cell Death and Differentiation · 61 citations
https://doi.org/10.1038/s41418-021-00900-1
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
2021 · Scientific Reports · 52 citations
https://doi.org/10.1038/s41598-021-84913-3
Host cell and viral protease targets of human SERPINs identified by in silico docking
2025 · The EMBO Journal · 1 citations
https://doi.org/10.1038/s44318-025-00546-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat